Results 271 to 280 of about 672,015 (400)

Acute exacerbation of usual interstitial pneumonia after resection of lung cancer: CT manifestations of the preoperative lung

, 2011
Hisatoshi Sugiura
openalex   +1 more source

Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

American Journal of Respiratory and Critical Care Medicine, 2015
J. Kropski, Jason M. Pritchett, D. Zoz, Peter F. Crossno, C. Markin, E. Garnett, Amber L. Degryse, D. Mitchell, V. Polosukhin, O. Rickman, Leena Choi, D. Cheng, Melinda E. McConaha, Brittany R. Jones, L. Gleaves, Frank B. McMahon, J. Worrell, J. Solus, L. Ware, J. W. Lee, P. Massion, Rinat Zaynagetdinov, E. White, J. Kurtis, Joyce E. Johnson, S. Groshong, L. Lancaster, L. Young, M. Steele, John A. Phillips III, J. Cogan, J. Loyd, William E. Lawson, T. Blackwell   +33 more
semanticscholar   +1 more source

CXCR3/CXCL10 Axis‐Mediated T Cell Infiltration in the Lungs of Patients With HTLV‐1‐Associated Diseases: Implications for Subclinical Pulmonary Involvement

Journal of Medical Virology, Volume 98, Issue 1, January 2026.
Abstract HTLV‐1 is a retrovirus associated with adult T cell leukemia/lymphoma (ATL) and inflammatory diseases, including HTLV‐1‐associated myelopathy (HAM) and HTLV‐1‐associated bronchopneumonopathy (HAB). Although pulmonary complications are common in HTLV‐1‐associated diseases, the underlying mechanisms remain unclear.
Kanako Tsuchimoto, Ayasa Mori, Masakazu Tanaka, Shiho Arishima, Daisuke Kodama, Mika Dozono, Satoshi Nozuma, Hiroshi Takashima, Ryuji Kubota   +8 more
wiley   +1 more source

Rare variants in RTEL1 are associated with familial interstitial pneumonia.

American Journal of Respiratory and Critical Care Medicine, 2015
J. Cogan, J. Kropski, Min Zhao, D. Mitchell, Lynette C Rives, C. Markin, E. Garnett, Keri H Montgomery, W. Mason, David F McKean, J. Powers, Elissa Murphy, L. Olson, Leena Choi, D. Cheng, E. Blue, L. Young, L. Lancaster, M. Steele, K. Brown, M. Schwarz, T. Fingerlin, D. Schwartz, William E. Lawson, J. Loyd, Zhongming Zhao, J. Phillips, T. Blackwell   +27 more
semanticscholar   +1 more source

Impact of Environmental and Seasonal Factors on Spontaneous Pneumomediastinum With and Without Pneumorrhachis

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 1, January 2026.
ABSTRACT Spontaneous pneumomediastinum (SPM) with pneumorrhachis is rare but generally benign and self‐limiting. However, the impact of environmental and seasonal factors on SPM remains unclear. This study investigated their association with SPM onset and clinical outcomes.
Yu‐Wei Liu, Chieh‐Ni Kao, Chi‐Chang Ho, Shah‐Hwa Chou, Pau‐Chung Chen, Shu‐Hung Huang   +5 more
wiley   +1 more source

Harnessing Radiomics and Explainable AI for the Classification of Usual and Nonspecific Interstitial Pneumonia. [PDF]

J Clin Med
Refaee T, Aloofy O, Alduraibi K, Ageeli W, Alyami A, Mohtasib R, Majrashi N, Lambin P.   +7 more
europepmc   +1 more source

Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: 2‐Year Post‐Marketing Surveillance Data

Neurology and Clinical Neuroscience, Volume 14, Issue 1, Page 54-68, January 2026.
ABSTRACT Background Dimethyl fumarate (DMF) is an orally administered disease‐modifying drug used for the treatment of multiple sclerosis (MS) in numerous countries worldwide. Aim An ongoing post‐marketing surveillance (PMS) is assessing the real‐world safety and effectiveness of DMF in Japanese patients with MS.
Hirofumi Ochi, Toshiyuki Fukazawa, Takashi Yamamura, Kazumasa Yokoyama, Takashi Ohashi, Ichiro Nakashima, Masanori Mizuno, Hikoaki Fukaura, Izumi Kawachi, Tatsusada Okuno, Ryusuke Sato, Haruki Makioka, Aya Tsuchiya, Michihiro Kanda, Yayoi Sato, Takahiko Saida   +15 more
wiley   +1 more source

Lung transplantation outcomes of patients with interstitial pneumonia with autoimmune features: a single-centre retrospective cohort study. [PDF]

Rheumatology (Oxford)
Yu ACM, Kim H, Levy RD, Wilson JM, Jalaledin DS, Choi J, Yee J, Poirier CD, Hoa SA, Landon-Cardinal O, Huang K.   +10 more
europepmc   +1 more source

III. Pulmonary Diseases Complicated with COPD - Lung Cancer and Pulmonary Fibrosis/Interstitial Pneumonia -

, 2018
Takafumi Suda
openalex   +2 more sources

Exposure‐Efficacy Meta‐Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 1, January 2026.
ABSTRACT The tyrosine kinase inhibitor, nintedanib, reduces the rate of decline in forced vital capacity (FVC) in a comparable manner in patients with idiopathic pulmonary fibrosis (IPF), other forms of progressive pulmonary fibrosis (PPF), and systemic sclerosis‐associated ILD (SSc‐ILD).
Sonja Hartmann, Julie Janssen, Jakob Ribbing, Susanne Stowasser, Julia Korell   +4 more
wiley   +1 more source